Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances R Levin

Showing results (171-180 of 262) with videos related to

Pageof 27
Sort By:
Journal of Dual Diagnosis|May 12, 2009
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open TrialFrances R Levin, John J Mariani, Alex Secora, et al.
Pediatrics|December 22, 2025
Cannabis Use Among US AdolescentsRyan S Sultan, Alexander W Zhang, Timothy D Becker, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
Drug and Alcohol Dependence|January 8, 2021
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
Pain Medicine (Malden, Mass.)|August 19, 2021
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort StudyJonathan Ross, Deepika E Slawek, Chenshu Zhang, et al.
Alcoholism, Clinical and Experimental Research|June 13, 2021
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorderJohn J Mariani, Martina Pavlicova, Cale Basaraba, et al.
The American Journal of Drug and Alcohol Abuse|October 4, 2023
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorderJohn J Mariani, Cale Basaraba, Martina Pavlicova, et al.
Pageof 27

Showing results (171-180 of 262) with videos related to

Sort By:
Pageof 27
Journal of Dual Diagnosis|May 12, 2009
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open TrialFrances R Levin, John J Mariani, Alex Secora, et al.
Pediatrics|December 22, 2025
Cannabis Use Among US AdolescentsRyan S Sultan, Alexander W Zhang, Timothy D Becker, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
Drug and Alcohol Dependence|January 8, 2021
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
Pain Medicine (Malden, Mass.)|August 19, 2021
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort StudyJonathan Ross, Deepika E Slawek, Chenshu Zhang, et al.
Alcoholism, Clinical and Experimental Research|June 13, 2021
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorderJohn J Mariani, Martina Pavlicova, Cale Basaraba, et al.
The American Journal of Drug and Alcohol Abuse|October 4, 2023
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorderJohn J Mariani, Cale Basaraba, Martina Pavlicova, et al.
Pageof 27